Q1FY19 result highlights
Rallis reported revenue growth above our expectation, however PAT was in-line with our estimates.
Key positives: Healthy volume growth and realisation in domestic pesticides and international business
Key negatives: Decline in Gross margins
Impact on financials: Cut EPS by 4.9%/3% for FY19E/20E respectively to factor in decline in gross margins
Our view
Rallis reported robust revenue growth in Q1FY19 led by healthy volume growth in the domestic pesticides business as well as export business. Despite strong revenue growth, sharp increase in raw material costs impacted profitability. Going forward ,we expect the revenue growth momentum to continue with new product launches and normal monsoons supported by Rallis’s strong distribution network, while lower inventory write-offs in seed business would lead to recovery in margins. Moreover, Rallis’s plans to collaborate with peers or backward integrate for 2-3 key raw materials which it imports from China augurs well on account of supply-side constraints from China. In the long run we believe, potential success in new formulations, commercialisation of new products under contract manufacturing and scale up in the seeds business are key triggers for the stock. Moreover introduction of several measures focused on improving farm income (MSP hikes) and normal monsoons in key geographies augurs well for Rallis. We maintain Outperformer on the stock with revised target price of Rs257 which is at 20x FY20E EPS of Rs12.8/sh
Rallis India Limited is engaged in the business of manufacture and marketing of Agri Inputs. The Company has its manufacturing facilities in India and sells both in India and across the globe. The Company's segments include Agri-Inputs and Others. The Agri-Inputs segment consists of Pesticides, Plant Growth Nutrients (PGN) and Seeds. The Other segment consists of Polymer. The Company's Non-Pesticide Portfolio includes Agri Services. Its Agri Services portfolio consists of the organic manure product GeoGreen, Samrudh Krishi (SK) initiative, MoPu (More Pulses) initiative and agri implements. The Company's products for crop protection, such as fungicides, including Contaf, Contaf Plus, Master and Fujione; weedicides, including Fateh, Tata Metri, Tata Panida, and insecticides, including Tata Mida, Reeva, Asataf and Manik. The Company also offers various category of products, including hybrid maize, hybrid paddy, hybrid pearl millet, mustard and wheat.
IDFC Securities Ltd., a subsidiary of the Infrastructure Development Finance Company (IDFC) wherein the Government of India holds a 20% interest, is India's leading equities broker catering to most of the prominent financial institutions, both foreign and domestic investing in Indian equities. A research team of experienced and dedicated experts ensures the flow of critically investigated stock ideas and portfolio strategies for our clients. Our coverage spans across various growth sectors such as agriculture, automobiles, Consumer Goods, Technology, Healthcare, Infrastructure, Media, Power, Real Estate, Telecom, Capital Goods, Logistics, Cement amongst other sectors. Our clients value us for our strong research-led investment ideas, superior client servicing track record and exceptional execution skills.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.